Andalusian Public Health System Virtual Library
RESEARCH+

One of INiBICA's priorities is to promote the development of the research activity of its groups in order to increase their competitiveness at national and international level, and in terms of scientific excellence and scientific, healthcare and social impact through the transfer of these results to the clinic and the market. This Plan 2023 is developed with the main objective of promoting, with the Institute's own funds, actions that promote the activity and training of research personnel. The mission is to improve the functioning of our Institute, in the process of consolidation and accreditation by ministerial order, through strategic actions aimed at increasing compliance with the indicators required for INiBICA accreditation, based on the guide published by the Instituto de Salud Carlos III (ISCIII) and the actions included in the Strategic Plan of INiBICA 2021-2025.

INiBICA's Own Plan 2023 is conceived as a complementary plan to the Own Research and Transfer Plan of the University of Cádiz, Research, Development and Innovation Plans of the Autonomous Community of Andalusia (PAIDI) and other National and International R&D Plans. Priority lines are established as the promotion of collaboration between groups, the mobility of personnel, the promotion of the activity of active emerging groups and the involvement of Primary Care and Health Care professionals, in line with the strategic I+i plans of the Regional Ministry of Health and Consumption, and of the ISCIII.

GENERAL PROVISIONS AND LINES OF FINANCING - INiBICA's OWN PLAN 2023

FIRST CALL

The first call for applications will begin on January 31, 2023 at 00:00 hours and will end on February 14, 2023 at 23:59 hours.

SECOND CALL

The deadline for submission of applications in this second call will begin on October 05, 2023 at 00:00 hours and will end on October 19, 2023 at 23:59 hours, through E-mail: planpropio@inibica.es.

Line 2 - Publications scientific excellence. Budget: 7,500 €.
Line 4 - Complementary grants. Modality 2: Support to Clinical Research Budget: 1.000 €.